Paul Knight
Stock Analyst
(2.67)
# 385
Out of 4,648 analysts
133
Total ratings
43.59%
Success rate
4.14%
Average return
Main Sectors:
Stocks Rated by Paul Knight
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
DHR Danaher | Maintains: Overweight | $290 → $310 | $246.70 | +25.66% | 9 | Oct 23, 2024 | |
CSTL Castle Biosciences | Maintains: Overweight | $25 → $28 | $33.19 | -15.64% | 6 | Mar 1, 2024 | |
RGEN Repligen | Maintains: Overweight | $210 → $220 | $138.41 | +58.95% | 7 | Feb 15, 2024 | |
WST West Pharmaceutical Services | Maintains: Overweight | $440 → $470 | $315.02 | +49.20% | 10 | Feb 13, 2024 | |
RVTY Revvity | Maintains: Overweight | $110 → $126 | $122.59 | +2.78% | 2 | Feb 2, 2024 | |
CDMO Avid Bioservices | Maintains: Overweight | $20 → $14 | $10.50 | +33.33% | 5 | Dec 8, 2023 | |
TECH Bio-Techne | Maintains: Overweight | $115 → $80 | $76.17 | +5.03% | 8 | Nov 1, 2023 | |
TMO Thermo Fisher | Downgrades: Sector Weight | n/a | $552.18 | - | 6 | Oct 26, 2023 | |
STVN Stevanato Group | Maintains: Overweight | $35 → $37 | $20.00 | +85.00% | 5 | Aug 30, 2023 | |
MRVI Maravai LifeSciences Holdings | Downgrades: Sector Weight | n/a | $7.79 | - | 8 | Aug 8, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $7.54 | - | 8 | Jul 17, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $6.76 | - | 1 | Jul 12, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $4 | $2.04 | +96.56% | 1 | Jul 12, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $138.15 | - | 8 | May 24, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $45.08 | - | 3 | May 10, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $5 → $7 | $2.40 | +192.28% | 4 | Apr 26, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $59.00 | - | 5 | Dec 19, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $51 → $40 | $22.39 | +78.69% | 6 | Sep 15, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $20 → $17 | $2.46 | +591.06% | 5 | May 13, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $60 → $30 | $25.26 | +18.76% | 4 | May 10, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $390 → $300 | $182.87 | +64.05% | 1 | May 5, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $290 → $250 | $208.23 | +20.06% | 1 | Apr 28, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $2.91 | - | 2 | Mar 14, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $382 → $441 | $208.54 | +111.47% | 1 | Jan 8, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $222 → $236 | $173.06 | +36.37% | 1 | Jan 8, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $92 → $99 | $105.30 | -5.98% | 1 | Jan 8, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $47 → $55 | $19.50 | +182.05% | 1 | Jan 8, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $385.36 | - | 4 | Nov 10, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $34.47 | - | 4 | Nov 10, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $117.85 | - | 1 | Nov 10, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $154.34 | - | 5 | Oct 23, 2017 |
Danaher
Oct 23, 2024
Maintains: Overweight
Price Target: $290 → $310
Current: $246.70
Upside: +25.66%
Castle Biosciences
Mar 1, 2024
Maintains: Overweight
Price Target: $25 → $28
Current: $33.19
Upside: -15.64%
Repligen
Feb 15, 2024
Maintains: Overweight
Price Target: $210 → $220
Current: $138.41
Upside: +58.95%
West Pharmaceutical Services
Feb 13, 2024
Maintains: Overweight
Price Target: $440 → $470
Current: $315.02
Upside: +49.20%
Revvity
Feb 2, 2024
Maintains: Overweight
Price Target: $110 → $126
Current: $122.59
Upside: +2.78%
Avid Bioservices
Dec 8, 2023
Maintains: Overweight
Price Target: $20 → $14
Current: $10.50
Upside: +33.33%
Bio-Techne
Nov 1, 2023
Maintains: Overweight
Price Target: $115 → $80
Current: $76.17
Upside: +5.03%
Thermo Fisher
Oct 26, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $552.18
Upside: -
Stevanato Group
Aug 30, 2023
Maintains: Overweight
Price Target: $35 → $37
Current: $20.00
Upside: +85.00%
Maravai LifeSciences Holdings
Aug 8, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $7.79
Upside: -
Jul 17, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $7.54
Upside: -
Jul 12, 2023
Initiates: Sector Weight
Price Target: n/a
Current: $6.76
Upside: -
Jul 12, 2023
Initiates: Overweight
Price Target: $4
Current: $2.04
Upside: +96.56%
May 24, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $138.15
Upside: -
May 10, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $45.08
Upside: -
Apr 26, 2023
Maintains: Overweight
Price Target: $5 → $7
Current: $2.40
Upside: +192.28%
Dec 19, 2022
Downgrades: Sector Weight
Price Target: n/a
Current: $59.00
Upside: -
Sep 15, 2022
Maintains: Overweight
Price Target: $51 → $40
Current: $22.39
Upside: +78.69%
May 13, 2022
Maintains: Overweight
Price Target: $20 → $17
Current: $2.46
Upside: +591.06%
May 10, 2022
Maintains: Overweight
Price Target: $60 → $30
Current: $25.26
Upside: +18.76%
May 5, 2022
Maintains: Overweight
Price Target: $390 → $300
Current: $182.87
Upside: +64.05%
Apr 28, 2022
Maintains: Overweight
Price Target: $290 → $250
Current: $208.23
Upside: +20.06%
Mar 14, 2022
Downgrades: Sector Weight
Price Target: n/a
Current: $2.91
Upside: -
Jan 8, 2021
Maintains: Overweight
Price Target: $382 → $441
Current: $208.54
Upside: +111.47%
Jan 8, 2021
Maintains: Overweight
Price Target: $222 → $236
Current: $173.06
Upside: +36.37%
Jan 8, 2021
Maintains: Overweight
Price Target: $92 → $99
Current: $105.30
Upside: -5.98%
Jan 8, 2021
Maintains: Overweight
Price Target: $47 → $55
Current: $19.50
Upside: +182.05%
Nov 10, 2020
Initiates: Sector Weight
Price Target: n/a
Current: $385.36
Upside: -
Nov 10, 2020
Initiates: Sector Weight
Price Target: n/a
Current: $34.47
Upside: -
Nov 10, 2020
Initiates: Sector Weight
Price Target: n/a
Current: $117.85
Upside: -
Oct 23, 2017
Upgrades: Neutral
Price Target: n/a
Current: $154.34
Upside: -